Author details

Full Name

Sharmistha Pal

Affiliation

ORCID

Career Start Year

2003

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
29760046	Dual HDAC and PI3K Inhibition Abrogates NFÎºB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas.	Cancer Res	2018
26188015	Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.	Neuro Oncol	2016
26041838	Correction for Patro et al., Shift in Monocyte Apoptosis with Increasing Viral Load and Change in Apoptosis-Related ISG/Bcl2 Family Gene Expression in Chronically HIV-1-Infected Subjects.	J Virol	2015
25355877	Shift in monocyte apoptosis with increasing viral load and change in apoptosis-related ISG/Bcl2 family gene expression in chronically HIV-1-infected subjects.	J Virol	2015
25030914	Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seq.	Methods Mol Biol	2014
24503249	Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes.	Nucleic Acids Res	2014
23594586	Isoform level expression profiles provide better cancer signatures than gene level expression profiles.	Genome Med	2013
22095278	RP58/ZNF238 directly modulates proneurogenic gene levels and is required for neuronal differentiation and brain expansion.	Cell Death Differ	2012
22909788	Alternative transcription and alternative splicing in cancer.	Pharmacol Ther	2012
21794104	IsoformEx: isoform level gene expression estimation using weighted non-negative least squares from mRNA-Seq data.	BMC Bioinformatics	2011
20843783	Genome-wide mapping of RNA Pol-II promoter usage in mouse tissues by ChIP-seq.	Nucleic Acids Res	2011
21712398	Alternative transcription exceeds alternative splicing in generating the transcriptome diversity of cerebellar development.	Genome Res	2011
20122241	Annotation of gene promoters by integrative data-mining of ChIP-seq Pol-II enrichment data.	BMC Bioinformatics	2010
18694959	Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.	Molecular and Cellular Biology	2008
17043109	The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling.	Molecular and Cellular Biology	2007
17708529	Interplay between chromatin remodelers and protein arginine methyltransferases.	Journal of Cellular Physiology	2007
17627275	Low levels of miR-92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma.	EMBO Journal	2007
15696166	Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.	Nature Genetics	2005
16135788	The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.	Molecular and Cellular Biology	2005
15485929	Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes.	Mol Cell Biol	2004
14559996	mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.	Mol Cell Biol	2003